Loading...
Dernières publications
-
Liem Nguyen, Maud Lemoine, Gibril Ndow, Zachary Ward, Timothy Hallet, et al.. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis. The Lancet global health, 2024, 12 (1), pp.e66-e78. ⟨10.1016/S2214-109X(23)00467-9⟩. ⟨pasteur-04363873⟩
-
Luc Jaulmes, Youri Yordanov, Alexandre Descamps, Isabelle Durand-Zaleski, Aurélien Dinh, et al.. Effectiveness and Medicoeconomic Evaluation of Home Monitoring of Patients With Mild COVID-19: Covidom Cohort Study. Journal of Medical Internet Research, 2023, 25, pp.e43980. ⟨10.2196/43980⟩. ⟨hal-04142340⟩
-
Christiana Kartsonaki, J Kenneth Baillie, Noelia García Barrio, Joaquín Baruch, Abigail Beane, et al.. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19. International Journal of Epidemiology, 2023, 52 (2), pp.355-376. ⟨10.1093/ije/dyad012⟩. ⟨hal-04164628⟩
-
Paul Loubet, Linda Wittkop, Laetitia Ninove, Mathieu Chalouni, Benoit Barrou, et al.. One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort. Clinical Microbiology and Infection, 2023, 29 (3), pp.388.e1-388.e8. ⟨10.1016/j.cmi.2022.10.009⟩. ⟨hal-03822592⟩
-
Jade Ghosn, Delphine Bachelet, Marine Livrozet, Minerva Cervantes-Gonzalez, Julien Poissy, et al.. Prevalence of Post-Acute COVID-19 Symptoms Twelve Months after Hospitalisation in Participants Retained in Follow-up: Analyses Stratified by Gender from a Large Prospective Cohort. Clinical Microbiology and Infection, 2023, 29 (2), pp.254.e7-254.e13. ⟨10.1016/j.cmi.2022.08.028⟩. ⟨hal-03801797⟩
Le CIC-1417 sur Twitter
Documents en texte intégral
70
Notices
67
Mots clés
Awareness
AstraZeneca vaccine
Immunogenicity
Effectiveness
Cystic fibrosis
Adults
COVID-19
Incidence
Sleep
Determinant
EMA
Attitudes of health personnel
Attitude to health
HPV vaccine
Vaccination
AON
Clinical practice
Disinformation
Antiretroviral therapy
Attitude
Chronic kidney disease
Covid-19
Vaccine hesitancy
CERVICOVAGINAL SECRETIONS
Drug
1790GAHB F
Risk factors
Innate immunity
Adjuvant
Conjugate pneumococcal vaccine
Cohort
Biomarkers
SARS-CoV-2
Covidom
Diabetes mellitus type 2
Conditional marketing authorization
Antiviral agents
Efficacy
DMD
Influenza
Digital care
Acute kidney injury
Epidemiology
Dialysis
Vaccine safety and efficacy
Déterminants
Antiviral
Vaccine
AIDS
Practices
COCONEL cohort surveys
Internet
Cancer
Assay
Healthcare workers
Determinants
Cost of illness
Data sharing
HIV
Covid 19
Adverse effects
Cohort study
Co-morbidities
Deletion
Coronavirus
Elderly
C-type lectin receptor
Boys
Alpha variant
Adenoviral vector
Clinical research
Delphi study
Dendritic cells
France
Immunocompromised
EHealth literacy
Catch-up
Hesitancy
Clinical skills
ANTIRETROVIRAL THERAPY
Coadministration
Dose escalation
Vaccine effectiveness
Care management
Calcium phosphorus evaluation
Confidence
Attitudes
Immunization
Clinical trials
Digital health intervention
Vaccines
Misinformation
Antiviral therapy
Chemotherapy
Booster response
B-lymphocytes
Influenza-like illness
Vaccine acceptance
Respiratory syncytial virus
COVID-19 vaccines